المؤلفون: Norman Fultang, Ashley M. Schwab, Sophia McAneny-Droz, Alexander Grego, Stephanie Rodgers, Brian Vidal Torres, Diane Heiser, Peggy Scherle, Neha Bhagwat

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: MCL1, PBRM1, renal cancer, PRT1419, CDK9, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1343004/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/a51826064c8141df84713321fc7b43a7

المؤلفون: Norman Fultang, Ashley M. Schwab, Sophia McAneny-Droz, Alexander Grego, Stephanie Rodgers, Brian Vidal Torres, Diane Heiser, Peggy Scherle, Neha Bhagwat

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, MCL1, PBRM1, renal cancer, PRT1419, CDK9

Relation: https://figshare.com/articles/figure/Image_1_PBRM1_loss_is_associated_with_increased_sensitivity_to_MCL1_and_CDK9_inhibition_in_clear_cell_renal_cancer_tif/25131416

الاتاحة: https://doi.org/10.3389/fonc.2024.1343004.s001
https://figshare.com/articles/figure/Image_1_PBRM1_loss_is_associated_with_increased_sensitivity_to_MCL1_and_CDK9_inhibition_in_clear_cell_renal_cancer_tif/25131416